Hisamitsu Pharmaceutical Co Inc 2025 IR
Company: Hisamitsu Pharmaceutical Co Inc
Sector: Health Care
Country: Japan
Year: 2025
Type: IR
Pages: 35
Back to company
Hisamitsu Pharmaceutical Co Inc
Integrated Report (Japanese edition)
This integrated report from Hisamitsu Pharmaceutical Co Inc covers the company's sustainability initiatives and performance for 2025.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Mar 1, 2024 - Feb 28, 2025
Fiscal Year
2025
Type
Integrated Report
Language
Japanese
Pages
File Size
Standards & Assurance
No data available
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
No data available